ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

The Future of Genomics Is Now: Dr. Thomas C. Spelsberg discusses the clinical implications

by Tom Valeo • March 1, 2010

  • Tweet
  • Email
Print-Friendly Version

ORLANDO, Fla.—The genome project sequenced all three billion base pairs of human DNA, revealing the instructions cells need to build all the proteins in the body. But that was just a warm-up, according to Thomas C. Spelsberg, PhD, of the Mayo Clinic in Rochester, Minn.

You Might Also Like

  • University of Kansas Medical Center Chancellor Discusses Challenges in Future of Otolaryngology
  • Digital Efficiency: Panel discusses the inevitability of EMRs
  • The Great Unknowns: Panel discusses research on pediatric tonsillitis, ottitis, sinusitis
  • The Future of Email In Physician Communication
Explore This Issue
March 2010

“Medical genomics is evolving into individualized medicine,” Dr. Spelsberg said at a guest lecture at the Triological Society’s Combined Sections Meeting held here Feb. 4-7. “You can start looking at disease biomarkers, new targeted drugs, disease subcategories, predispositions to diseases and even pharmacogenomics, which is individualized drug metabolism. This is the future, folks.”

Dr. Spelsberg, the George M. Eisenberg Professor in the department of biochemistry and molecular biology at the Mayo Graduate School of Medicine, explained that medical genomics has given way to transcriptonomics, the study of all the mRNAs (messenger RNAs) that code for proteins. Other areas medical genomics has evolved into include preoteomics, the study of all the proteins in cells or organisms, and metabolomics, the study of the activity of cell proteins and enzymes.

Dr. Spelsberg said the knowledge produced by these emerging fields will enable physicians to customize diagnosis and treatment based on each patient’s genetic endowment. Already, researchers have identified about 10 “obesogenes” involved in the maintenance of body weight. Dr. Spelsberg displayed a photo of two rats side by side. One appeared normal, while the other was enormously fat. The fat mouse, he explained, lacked the gene for leptin, the hormone that triggers a feeling of satiety.

Polymorphisms

But the genes themselves are only part of the story. Genes also mutate or “morph” into polymorphisms that can leave the body more susceptible to dysfunction. Some polymorphisms are inherited, some develop over time. “Identical twins are born with the exact same DNA, but they develop polymorphisms with age and start to look different,” Dr. Spelsberg said. “They grow apart.”

The environment plays a role in developing polymorphisms. “People who live in cities get more polymorphisms,” Dr. Spelsberg said. “They say for every 15 cigarettes you smoke you develop a new polymorphism. Smokers have a lot more polymorphisms compared to nonsmokers. And people who get lots of sun have more polymorphisms in their skin. What they’re finding is that the more polymorphisms you get, the shorter your lifespan will be.”

Even though humans are 99.9 percent identical genetically, that remaining 0.1 percent amounts to three million polymorphisms. Most polymorphisms are nonfunctional, but some—about one in 30—alter the structure of the proteins produced by the cell, producing observable changes. A deeper understanding of how polymorphisms interact reveals subclasses of diseases.

Pages: 1 2 | Single Page

Filed Under: Departments, Medical Education, Tech Talk Tagged With: genes, genetics, genomics, personalized medicine, technologyIssue: March 2010

You Might Also Like:

  • University of Kansas Medical Center Chancellor Discusses Challenges in Future of Otolaryngology
  • Digital Efficiency: Panel discusses the inevitability of EMRs
  • The Great Unknowns: Panel discusses research on pediatric tonsillitis, ottitis, sinusitis
  • The Future of Email In Physician Communication

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Otolaryngologists Have a Major Role to Play in Treating COVID-19 Long-Haulers
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.